Robert Chou
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Protein purification and stability, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Field-Flow Fractionation Techniques, Innovation and Knowledge Management
Most-Cited Works
- → Conformational Difference in Human IgG2 Disulfide Isoforms Revealed by Hydrogen/Deuterium Exchange Mass Spectrometry(2015)41 cited
- → Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution(2011)34 cited
- → IgG2 disulfide isoform conversion kinetics(2013)26 cited
- → Protected hinge in the immunoglobulin G2‐A2 disulfide isoform(2014)16 cited
- → Impact of antibody subclass and disulfide isoform differences on the biological activity of CD200R and βklotho agonist antibodies(2017)11 cited
- → Rotational Rheology of Bovine Serum Albumin Solutions: Confounding Effects of Impurities, Mechanistic Considerations and Potential Implications on Protein Formulation Development(2018)7 cited
- → A Tiered Approach for Characterization to Ensure Quality, Reproducibility, and Long-Term Stability of Critical Reagents in Regulated Bioanalysis to Support PK/ADA/NAb Assays for Biologics and Vaccines Programs(2020)7 cited
- → Field-Flow Fractionation for Assessing Biomolecular Interactions in Solution(2011)3 cited
- STARTUPS AND INVESTORS AND TROLLS, OH MY!: HOW COMMERCIALIZATION PATENTS CAN BENEFIT STARTUP INNOVATION(2020)
- Recent Progress in Glycotherapy(2016)